BFO
RLAY icon

Boston Family Office’s Relay Therapeutics RLAY Stock Holding History

Boston Family Office’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,397
Closed -$65K – 317
2025
Q3 		$65K Hold
12,397
– – ﹤0.01% 295
2025
Q2 		$43K Hold
12,397
– – ﹤0.01% 284
2025
Q1 		$32K Hold
12,397
– – ﹤0.01% 279
2024
Q4 		$51K Hold
12,397
– – ﹤0.01% 273
2024
Q3 		$88K Hold
12,397
– – 0.01% 275
2024
Q2 		$81K Hold
12,397
– – 0.01% 264
2024
Q1 		$103K Hold
12,397
– – 0.01% 261
2023
Q4 		$136K Hold
12,397
– – 0.01% 257
2023
Q3 		$104K Hold
12,397
– – 0.01% 251
2023
Q2 		$156K Hold
12,397
– – 0.01% 256
2023
Q1 		$204K Hold
12,397
– – 0.02% 256
2022
Q4 		$185K Sell
12,397
-350
-3% -$6.7K 0.02% 264
2022
Q3 		$286K Hold
12,747
– – 0.03% 229
2022
Q2 		$214K Hold
12,747
– – 0.02% 258
2022
Q1 		$382K Hold
12,747
– – 0.03% 226
2021
Q4 		$391K Buy
12,747
+350
+3% +$11.1K 0.03% 230
2021
Q3 		$391K Sell
12,397
-8,724
-41% -$294K 0.03% 222
2021
Q2 		$773K Hold
21,121
– – 0.06% 175
2021
Q1 		$730K Hold
21,121
– – 0.05% 177
2020
Q4 		$878K Hold
21,121
– – 0.07% 168
2020
Q3 		$900K Buy
+21,121
New +$805K 0.08% 154

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Family Office's RLAY Position: Q4 2025 in Review

Boston Family Office sold out of Relay Therapeutics (RLAY) in Q4 2025, closing a stake of 12,397 shares — an estimated $65K sold.

Boston Family Office first reported a position in RLAY in Q3 2020 and held it in 21 quarters. The position peaked at $900K in Q3 2020. 226 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

  • Boston Family Office reported no remaining Relay Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Boston Family Office sold 12,397 Relay Therapeutics shares in Q4 2025, an estimated $65K.
  • Boston Family Office first reported a position in Relay Therapeutics in Q3 2020 and held it in 21 quarters.
  • Boston Family Office's Relay Therapeutics position peaked at $900K in Q3 2020.
  • 226 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on Boston Family Office's 13F filing for Q4 2025, filed 13 Feb 2026.